SCHIFF ANDREW N

CIK 000117225221 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001172252

Recent Transactions

50 trades

Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-06-13+30,700→ 30,700 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-06−4,793→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-06-06+4,793→ 13,960 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-05+11,580→ 11,580 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-12+22,100→ 22,100 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-06+4,793→ 4,793 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 9,167 total
Award
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-06-14+20,500→ 20,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-11-14$17.08/sh−1,371→ 434,455 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-11-11$17.06/sh−41,160→ 435,826 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-11-10$17.02/sh−11,395→ 476,986 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-26$17.00/sh−14,540→ 488,381 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-25$17.02/sh−12,018→ 502,921 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-24$17.01/sh−14,616→ 514,939 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-18$16.89/sh−32,093→ 529,555 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-17$16.05/sh−19,944→ 561,648 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-07$16.16/sh−7,324→ 581,592 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-06$16.54/sh−37,839→ 588,916 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-10-04$16.01/sh−7,700→ 626,755 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-17$15.14/sh−19,565→ 0 total
Award
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2022-06-17+15,619→ 15,619 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-06-15+15,000→ 15,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Conversion
Elevation Oncology, Inc.
Series B Preferred Stock
2021-06-29−1,936,834→ 0 total
Conversion
Elevation Oncology, Inc.
Series A Preferred Stock
2021-06-29−8,000,000→ 0 total
Purchase
Elevation Oncology, Inc.
Common Stock
2021-06-29$16.00/sh+187,500→ 2,834,910 total
Conversion
Elevation Oncology, Inc.
Common Stock
2021-06-29+458,360→ 2,647,410 total
Conversion
Elevation Oncology, Inc.
Common Stock
2021-06-29+1,893,232→ 2,189,050 total
Award
Elevation Oncology, Inc.
Director Stock Option
2021-06-24+31,238→ 31,238 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+47,132→ 47,132 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-06-06−7,333→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-06+7,333→ 16,209 total
Award
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2020-06-04+16,500→ 16,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+8,876→ 8,876 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−8,876→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+8,876→ 8,876 total
Award
Zosano Pharma Corp
Common Stock, par value of $0.0001
2019-12-02$1.45/sh+689,655→ 2,718,226 total

Recent Filings

Address

888 SEVENTH AVENUE THIRTIETH FLOOR

NEW YORK, NY, 10106

View on SEC.gov